AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24450889
Drug: Isoniazid preventive
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid preventive therapy for 9 months
Trial: 24450889
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no isoniazid preventive therapy)
Trial: 24450889
Drug: Intervention clusters
RxNorm normalized name: cluster fig extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention clusters (mass screening and treatment)
Trial: 22672970
Drug: 100mg/m² weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100mg/m² weekly gemcitabine with 3D conformal radiotherapy delivering 55 Gy in 20 fractions over 4 weeks (Arm B)
Trial: 19128941
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy (NRT) trials
Trial: 19128941
Drug: Patch trials
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch trials
Trial: 19128941
Drug: Trials funded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trials funded by the pharmaceutical industry
Trial: 17496226
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy based on Fe(NO) measurements (n = 58)
Trial: 17496226
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy based on Fe(NO) measurements
Trial: 10926311
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg ALA orally per day over 6 weeks
Trial: 10926311
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg ALA intravenously over 15 minutes
Trial: 1626957
Drug: Preoperative therapy-ACNU
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative therapy-ACNU
Trial: 1626957
Drug: ACNU combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACNU combination group
Trial: 6497641
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate 1 mg/kg (Group 1)
Trial: 6497641
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate 1 mg/kg (Group 2)
Trial: 6497641
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate 4 mg/kg (Group 3)
Trial: 27340931
Drug: Fish Oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish Oil (FO) supplementation at 4 g/day
Trial: 20392399
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (100 microg, 4 hourly, maximum of 2 doses)
Trial: 20392399
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (50 microg, 4 hourly, maximum of 2 doses)
Trial: 27950588
Drug: Aggressive range
RxNorm normalized name: Orange
DrugBank: Orange (DB10549)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive range of motion (ROM) exercises with postural sensory therapy
Trial: 27950588
Drug: Postural sensory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postural sensory therapy alone (PS)
Trial: 27950588
Drug: Both therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both therapy protocols
Trial: 14570643
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% continuous infusion at 5 mL/h for up to 48 h after surgery
Trial: 14570643
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% continuous infusion
Trial: 10761161
Drug: Erythromycin ethylsuccinate
RxNorm normalized name: Erythromycin Ethylsuccinate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin ethylsuccinate (EES) 200 mg given orally 10 minutes after i.m. treatments
Trial: 10761161
Drug: Intramuscular saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular saline (SAL, 0.5 ml), scopolamine (SCP, 0.1 mg), or promethazine (PMZ, 25 mg)
Trial: 8883527
Drug: Iodixanol at
RxNorm normalized name: Iodixanol
DrugBank: Iodixanol (DB01249)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iodixanol at 320 mg I/ml (IOD‐320)
Trial: 8883527
Drug: Iohexol at
RxNorm normalized name: Iohexol
DrugBank: Iohexol (DB01362)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iohexol at 300 mg I/ml (IOH‐300)
Trial: 26549402
Drug: Rabeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (20 mg/d)
Trial: 19487925
Drug: Quifenadine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quifenadine (2 mg kg(‐1) day(‐1); n = 54)
Trial: 19487925
Drug: Amiodarone (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (9 mg kg(‐1) day(‐1); n = 50)
Trial: 15543591
Drug: Interferon (IFN)
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (IFN) alpha‐2b induction (6 MU daily for 2 weeks) followed by 6 MU thrice weekly for 46 weeks (IFN/R group)
Trial: 15543591
Drug: Pegylated IFN
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated IFN alpha‐2b (1.5 microg/kg) weekly for 48 weeks in combination with ribavirin (600‐1,000 mg daily) (PEG/R group)
Trial: 12784066
Drug: WEB 2086
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: WEB 2086 gel (3%)
Trial: 8777104
Drug: Edrophonium 1
RxNorm normalized name: edrophonium 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium 1 mg kg‐1 administered 2 min after maximum block (intense block group)
Trial: 8777104
Drug: Edrophonium 1
RxNorm normalized name: edrophonium 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium 1 mg kg‐1 administered after 10% recovery of T1 (conventional reversal group)
Trial: 8777104
Drug: Edrophonium 1
RxNorm normalized name: edrophonium 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium 1 mg kg‐1 (intense block group)
Trial: 8777104
Drug: Edrophonium 1
RxNorm normalized name: edrophonium 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium 1 mg kg‐1 (conventional reversal group)
Trial: 8777104
Drug: Edrophonium 1
RxNorm normalized name: edrophonium 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium 1 mg kg‐1 (spontaneous recovery group)
Trial: 1802194
Drug: Aspirin (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (180 mg daily) with fat-modified control diet
Trial: 6185209
Drug: BLM‐MTX (bleomycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BLM‐MTX (bleomycin 30 mg intravenously twice weekly, methotrexate 25 mg intravenously twice weekly for 2 1/2 and two weeks, respectively)
Trial: 6185209
Drug: CMF (methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF (methotrexate 25 mg twice weekly for two weeks, Cytoxan 100 mg/day for two weeks, 5‐FU 500 mg twice weekly for 1 1/2 weeks)
Trial: 23670111
Drug: Attention-control treatment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Attention-control treatment, healthy lifestyle tips (HT)
Trial: 19298338
Drug: Concomitant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant therapy (duration 3 to 5 days)
Trial: 19298338
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (duration 5 to 10 days)
Trial: 11686818
Drug: Braun Oral‐B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun Oral‐B 3D Plaque Remover D15
Trial: 9215844
Drug: Urokinase with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urokinase with heparin (320 U/h)
Trial: 29758039
Drug: Palonosetron (0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron (0.075 mg, intravenous)
Trial: 27159993
Drug: Sativex(®) oral
RxNorm normalized name: Castanea sative leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sativex(®) oral spray, up to 12 sprays/day for 12 weeks
Trial: 27159993
Drug: Placebo oral
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo oral spray, up to 12 sprays/day for 12 weeks
Trial: 23579427
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose alcohol (0.8 g/kg)
Trial: 23579427
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose alcohol (0.4 g/kg)
Trial: 23579427
Drug: Alcohol dose
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol dose and outcome expectancies
Trial: 11202126
Drug: Unspecific supportive
RxNorm normalized name: Caviar, unspecified
DrugBank: Caviar, unspecified (DB14241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unspecific supportive control therapy
Trial: 7492128
Drug: Topical emollients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical emollients (Control)
Trial: 232697
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg pivmecillinam four times daily for seven days
Trial: 232697
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg ampicillin four times daily for seven days
Trial: 31727676
Drug: GX-188E injection
RxNorm normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GX-188E injection
Trial: 25927321
Drug: Breezhaler (single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breezhaler (single-dose inhaler)
Trial: 21262317
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg caffeine
Trial: 14644398
Drug: Probucol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probucol (500 mg per day)
Trial: 14644398
Drug: Pravastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (10 mg per day)
Trial: 14644398
Drug: C. pneumoniae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C. pneumoniae antibody positive patients
Trial: 10723666
Drug: Single 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 200 mg dose of levofloxacin (LVFX)
Trial: 10723666
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of levofloxacin (LVFX) administered twice a day for three days
Trial: 8160955
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl 10 micrograms/ml with 0.1% bupivacaine (group FB)
Trial: 8160955
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl 10 micrograms/ml without bupivacaine (group F)
Trial: 16595614
Drug: Gabapentin 1,600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 1,600 mg
Trial: 14609606
Drug: LDL cholesterol
RxNorm normalized name: LDL cholesterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL cholesterol <70 mg/dl
Trial: 14609606
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy with LDL cholesterol <100 mg/dl
Trial: 8769601
Drug: RSHZ19 (0.025‐10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RSHZ19 (0.025‐10.0 mg/kg)
Trial: 8769601
Drug: RSHZ19 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RSHZ19 (10 mg/kg)
Trial: 8769601
Drug: RSHZ19 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RSHZ19 (5 mg/kg)
Trial: 8311368
Drug: Current smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current smoking (20 or more cigarettes daily)
Trial: 8311368
Drug: Current smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current smoking (fewer than 20 cigarettes daily)
Trial: 2905133
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg temazepam (Planum)
Trial: 29697011
Drug: Vibratory vest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vibratory vest therapy (Vest)
Trial: 20964769
Drug: Acetaminophen alone
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen alone (40 mg·kg(‐1) rectal)
Trial: 20964769
Drug: Acetaminophen and
RxNorm normalized name: Acetaminophen and Aspirin Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen and intranasal fentanyl (1 mcg·kg(‐1))
Trial: 20964769
Drug: Acetaminophen and
RxNorm normalized name: Acetaminophen and Aspirin Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen and intramuscular ketorolac (1 mg·kg(‐1))
Trial: 10740141
Drug: Candesartan (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (initial dosage 4 mg/d, increased to 16 mg/d if tolerated)
Trial: 1376362
Drug: Buprenorphine (0.5-8.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (0.5-8.0 mg)
Trial: 6722464
Drug: Subcutaneous sphincterotomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous sphincterotomy
Trial: 30043449
Drug: SQ house
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ house dust mite sublingual immunotherapy-tablet (10,000 JAU)
Trial: 25280421
Drug: Zinc acetate
RxNorm normalized name: Zinc Acetate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc acetate preparation at a dose of 3 capsules/d for a total zinc content of 150 mg/d (Z group)
Trial: 22850072
Drug: Standard 4-drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard 4-drug therapy (Metronidazole 500 mg/BD, Amoxicillin 1g/BD, Omeprazole 20mg/BD, Bismuth 240 mg/BD) + Lycopene (30 mg/daily)
Trial: 22850072
Drug: Standard 4-drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard 4-drug therapy (Metronidazole 500 mg/BD, Amoxicillin 1g/BD, Omeprazole 20mg/BD, Bismuth 240 mg/BD)
Trial: 19549250
Drug: Insulin-glucose infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-glucose infusion therapy
Trial: 7842769
Drug: Bambuterol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol (20 mg tablet) - morning administration
Trial: 7842769
Drug: Bambuterol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol (20 mg tablet) - evening administration
Trial: 2297349
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (3.8 g of n-3 fatty acids)
Trial: 24007456
Drug: Empagliflozin 25
RxNorm normalized name: empagliflozin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 25 mg once daily (qd)
Trial: 24007456
Drug: Glimepiride 1-4
RxNorm normalized name: glimepiride 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride 1-4 mg qd
Trial: 15841998
Drug: Intranasal endoscopic
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal endoscopic sphenopalatine artery ligation (ESAL)
Trial: 9402071
Drug: Nucleoside (zidovudine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nucleoside (zidovudine 600 mg/day and zalcitabine 2.25 mg/day)
Trial: 31094746
Drug: Dextromethorphan (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (30 mg)
Trial: 3659583
Drug: Dextromethorphan +
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan + Salbutamol (30 mg + 2 mg)
Trial: 27207493
Drug: Local cold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local cold gel pack
Trial: 27207493
Drug: Local cold-hot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local cold-hot gel pack
Trial: 25049242
Drug: DHA-PQ with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-PQ with 8.5 g fat (group B)
Trial: 22946930
Drug: i.v. ibandronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. ibandronate 3 mg every 3 months for 12 months
Trial: 18940086
Drug: Listening to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Listening to a radio transmission (oral medium)
Trial: 12888874
Drug: Enoxaparin (subcutaneous,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (subcutaneous, twice daily)
Trial: 12888874
Drug: UFH (intravenous)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFH (intravenous)
Trial: 9368703
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg acarbose plus 10 ml antacid suspension
Trial: 9368703
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml antacid suspension
Trial: 3887887
Drug: 500 g
RxNorm normalized name: PRAZIQUANTEL 500 g in 500 g POWDER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 g naturally labeled 13C carbohydrate after high fat antecedent diet
Trial: 3887887
Drug: 500 g
RxNorm normalized name: PRAZIQUANTEL 500 g in 500 g POWDER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 g naturally labeled 13C carbohydrate after mixed antecedent diet
Trial: 3887887
Drug: 500 g
RxNorm normalized name: PRAZIQUANTEL 500 g in 500 g POWDER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 g naturally labeled 13C carbohydrate after high carbohydrate antecedent diet
Trial: 28738709
Drug: Nebulized hypertonic
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized hypertonic saline solution (HSS) twice daily
Trial: 27167367
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (standard care with traditional physical therapy)
Trial: 25050903
Drug: Single session
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single session of ultrasound-guided laser ablation therapy (LAT) using a 1064nm Nd-YAG laser source at 3 W output power.
Trial: 25050903
Drug: Follow-up with
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follow-up with no treatment (Control group).
Trial: 18705707
Drug: Above-median fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Above-median fluid intake (24 ml/kg/day)
Trial: 18705707
Drug: Below-median fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Below-median fluid intake (16 ml/kg/day)
Trial: 16051399
Drug: Lactobacillus reuteri
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus reuteri ATCC 55730, 1x10(8) cfu/tablet twice a day for 6 months
Trial: 11824856
Drug: L-arginine 100
RxNorm normalized name: RITE AID L-Arginine 1000mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine 100 mg/kg
Trial: 11824856
Drug: L-arginine 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine 250 mg/kg
Trial: 11824856
Drug: L-arginine 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine 250 mg/kg with L-NMMA
Trial: 11824856
Drug: L-NMMA before
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA before L-arginine infusion
Trial: 11824856
Drug: Subsequent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subsequent infusion of L-arginine after L-NMMA
Trial: 10073501
Drug: Hyaluronan loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyaluronan loading test with intravenous injection of 7.5 mg HYA
Trial: 7722709
Drug: High protein-energy
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein-energy supplement (Atole)
Trial: 7722709
Drug: Low-energy, no-protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-energy, no-protein supplement (Fresco)
Trial: 2183665
Drug: Ibuprofen, 800
RxNorm normalized name: Ibuprofen, 800 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen, 800 mg three times daily
Trial: 2183665
Drug: Piroxicam, 20
RxNorm normalized name: Piroxicam, 20 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam, 20 mg daily
Trial: 2183665
Drug: Sulindac, 200
RxNorm normalized name: Sulindac, 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac, 200 mg twice daily
Trial: 2183665
Drug: Ibuprofen, piroxicam,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen, piroxicam, and sulindac (combined)
Trial: 6276883
Drug: Calcium therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium therapy (Control group, n = 9)
Trial: 31923471
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (INI) 40 IU daily for 24 weeks
Trial: 30799103
Drug: Twice-a-day milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-a-day milk feeding with live yeast culture and mannan-rich fraction
Trial: 30799103
Drug: Twice-a-day milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-a-day milk feeding without yeast
Trial: 30799103
Drug: Calves fed
RxNorm normalized name: AmproMed for Calves
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calves fed milk twice a day